CA1054520A - L-ascorbic acid tablets - Google Patents
L-ascorbic acid tabletsInfo
- Publication number
- CA1054520A CA1054520A CA249,080A CA249080A CA1054520A CA 1054520 A CA1054520 A CA 1054520A CA 249080 A CA249080 A CA 249080A CA 1054520 A CA1054520 A CA 1054520A
- Authority
- CA
- Canada
- Prior art keywords
- ascorbic acid
- weight percent
- granules
- weight
- binder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50090742A JPS58403B2 (ja) | 1975-07-24 | 1975-07-24 | L− アスコルビンサンセイザイノ セイゾウホウ |
US05/610,003 US4036948A (en) | 1975-07-24 | 1975-09-03 | L-ascorbic acid tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1054520A true CA1054520A (en) | 1979-05-15 |
Family
ID=26432181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA249,080A Expired CA1054520A (en) | 1975-07-24 | 1976-03-29 | L-ascorbic acid tablets |
Country Status (8)
Country | Link |
---|---|
CA (1) | CA1054520A (xx) |
DE (1) | DE2616078C2 (xx) |
ES (1) | ES446464A1 (xx) |
FR (1) | FR2318621A1 (xx) |
GB (1) | GB1534066A (xx) |
HK (1) | HK2182A (xx) |
MX (1) | MX3239E (xx) |
NL (1) | NL184308C (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
DE3891219T1 (de) * | 1988-01-22 | 1990-02-01 | Kh Nii Endokrinologii I Chimii | P-chlorphenoxysobuttersaeureundezylester und arzneimittel auf dessen grundlage zur behandlung der hyperlipidaemie |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
JP4098376B2 (ja) * | 1996-09-05 | 2008-06-11 | ビーエーエスエフ ソシエタス・ヨーロピア | 錠剤特性の優れた水溶性ビタミン組成物およびその製造法 |
DE19733094A1 (de) * | 1997-07-31 | 1999-02-04 | Merck Patent Gmbh | Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3453368A (en) * | 1966-01-13 | 1969-07-01 | Hoffmann La Roche | Smaller high potency compressed tablets of ascorbic acid |
-
1976
- 1976-03-12 NL NL7602657A patent/NL184308C/xx not_active IP Right Cessation
- 1976-03-26 GB GB1221176A patent/GB1534066A/en not_active Expired
- 1976-03-29 ES ES446464A patent/ES446464A1/es not_active Expired
- 1976-03-29 CA CA249,080A patent/CA1054520A/en not_active Expired
- 1976-03-29 FR FR7609066A patent/FR2318621A1/fr active Granted
- 1976-03-30 MX MX12876U patent/MX3239E/es unknown
- 1976-04-13 DE DE19762616078 patent/DE2616078C2/de not_active Expired
-
1982
- 1982-01-14 HK HK2182A patent/HK2182A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE2616078A1 (de) | 1977-02-10 |
HK2182A (en) | 1982-01-22 |
FR2318621A1 (fr) | 1977-02-18 |
GB1534066A (en) | 1978-11-29 |
NL184308B (nl) | 1989-01-16 |
DE2616078C2 (de) | 1985-05-15 |
MX3239E (es) | 1980-08-06 |
NL7602657A (nl) | 1977-01-26 |
ES446464A1 (es) | 1977-10-16 |
FR2318621B1 (xx) | 1979-03-30 |
NL184308C (nl) | 1989-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4036948A (en) | L-ascorbic acid tablets | |
CA1244768A (en) | Sugar and starch free spray-dried vitamin c powder containing 90 percent ascorbic acid | |
US4072535A (en) | Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules | |
US3622677A (en) | Compressed tablets containing compacted starch as binder-disintegrant ingredient | |
EP0487774B1 (en) | A direct tabletting auxiliary | |
US4427648A (en) | Dipyridamole-containing pharmaceutical form | |
US4702919A (en) | Granules of thiamine salt and the production thereof | |
US4372968A (en) | Granules of sodium ascorbate and the production thereof | |
CA1261261A (en) | Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation | |
JPH0751504B2 (ja) | 直打用ビタミン顆粒、その製造法および錠剤 | |
AU2006260201B2 (en) | Tablet containing hardly soluble active ingredient | |
CN109432022B (zh) | 一种含酒石酸伐尼克兰的药物组合物及其制备方法 | |
JP2017520627A (ja) | コロイドビスマスペクチンを含有する分散製剤及びその製造方法 | |
CN106822017A (zh) | 一种磷酸西格列汀片及其制备方法 | |
CN112494445A (zh) | 一种马来酸氟伏沙明组合物及其制备方法 | |
US4520009A (en) | Sustained released aspirin formulation | |
CA1054520A (en) | L-ascorbic acid tablets | |
EP0196546B1 (en) | Pharmaceutical tableting method | |
EA000913B1 (ru) | Таблетка меченной изотопом мочевины | |
US5334393A (en) | Sustained-release tablet based on isosorbide 5-mononitrate and process for preparing it | |
DE3045488C2 (xx) | ||
KR20010057578A (ko) | 아스코르브산 및 펙틴을 포함하는 조성물 | |
US5534551A (en) | Aminoguanidine spray drying process | |
JPWO2004006945A1 (ja) | 漢方エキス含有錠剤組成物およびその製造方法 | |
CN107320440B (zh) | 含萝卜硫素胃滞留组合物及其制备方法 |